Wockhardt

This study tested a new antibiotic called cefepime-zidebactam against a standard antibiotic (meropenem) in about 530 adults hospitalized with complicated urinary tract infections or kidney infections. The goal was to see if the new drug works as well and is safe. Participants rec…

This study looked at how healthy men break down and get rid of the antibiotic zidebactam. Eight participants received a single dose with a radioactive tracer to track the drug in urine and stool. The goal was purely to understand the drug's metabolism and excretion, not to treat …

This early-stage study tested the safety and tolerability of multiple doses of an experimental antibiotic called zidebactam given through a vein. Twenty-one healthy adults received either the drug or a placebo. The goal was to check for side effects and how the drug moves through…

This early-stage study tested the safety and how the body processes a new antibiotic combination (Zidebactam-Cefepime) when given alone or with another antibiotic (metronidazole). Thirty healthy adults received single doses of each drug separately and together. The goal was to ch…